We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GFS:NASDAQGlobalFoundries Inc. Analysis

Data as of 2026-05-24 - not real-time

$85.64

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GlobalFoundries is trading well above its 20‑day, 50‑day and 200‑day moving averages, with a bullish MACD histogram and an RSI that signals overbought conditions. The stock’s beta is notably higher than the market average and recent volatility has surged, while volume trends are weakening, suggesting heightened price sensitivity. A discounted cash‑flow model places fair value far below the current market price, and the trailing P/E sits well above the semiconductor industry average, indicating the equity may be overvalued at present.
However, the catalyst from a newly announced $375 million U.S. government quantum computing grant and the launch of a dedicated quantum technology division provides a compelling growth narrative. Revenue growth remains modest, margins are thin, and the dividend payout appears unsustainable given earnings constraints. These fundamentals, combined with sector‑specific cyclical risk and elevated market volatility, temper the enthusiasm from the technical upside.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • RSI in overbought territory raises near‑term pull‑back risk
  • Recent quantum grant provides immediate positive sentiment

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Quantum and photonics initiatives expected to drive revenue expansion
  • Strong upside potential if execution of new technology platforms succeeds
  • Current market price reflects premium that may compress as growth materializes

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term structural demand for advanced semiconductor manufacturing
  • Valuation remains stretched relative to DCF and peer multiples
  • High beta and volatility suggest cautious positioning over extended horizons

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin11.37%
P/E Ratio51.0
ROE6.83%
ROA3.09%
Debt/Equity14.68
P/B Ratio4.0
Op. Cash Flow$1.9B
Free Cash Flow$1.2B
Industry P/E39.5

Technical Analysis

TrendBullish
RSI74.4
Support$57.93
Resistance$89.90
MA 20$70.53
MA 50$57.04
MA 200$42.56
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$34.69
Target Price$78.95
Upside/Downside-7.81%
GradeOvervalued
TypeGrowth
Dividend Yield0.56%

Risk Assessment

Beta1.86
Volatility68.54%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.